KRAS c.49_51delinsGAG ;(p.S17E)

Variant ID: 12-25398268-ACT-CTC

NM_004985.3(KRAS):c.49_51delinsGAG;(p.S17E)

This variant was identified in 5 publications

View GRCh38 version.




Publications:


Elucidating the mechanism behind and investigating the efficacy of Traditional Chinese Medicine and Traditional Tibetan Medicine in combination with standard therapeutics in hepatocellular carcinoma and cholangiocarcinoma in vitro.

Frontiers In Pharmacology
Suo, Huizhen H; Hochnadel, Inga I; Petriv, Nataliia N; Franke, Raimo R; Schmidt, Jennifer J; Limanska, Nataliia N; Tugai, Alisa A; Jedicke, Nils N; Broenstrup, Mark M; Manns, Michael P MP; Yevsa, Tetyana T
Publication Date: 2022

Variant appearance in text: KRAS: S17E
PubMed Link: 36172191
Variant Present in the following documents:
  • Main text
View BVdb publication page



A saturation mutagenesis screen uncovers resistant and sensitizing secondary KRAS mutations to clinical KRASG12C inhibitors.

Proceedings Of The National Academy Of Sciences Of The United States Of America
Feng, Siyu S; Callow, Marinella G MG; Fortin, Jean-Philippe JP; Khan, Zia Z; Bray, David D; Costa, Mike M; Shi, Zhen Z; Wang, Weiru W; Evangelista, Marie M
Publication Date: 2022-05-03

Variant appearance in text: KRAS: S17E
PubMed Link: 35471904
Variant Present in the following documents:
  • pnas.202120512.pdf
  • pnas.2120512119.sapp.pdf
View BVdb publication page



Comprehensive Genomic Profiling of Neuroendocrine Carcinomas of the Gastrointestinal System.

Cancer Discovery
Yachida, Shinichi S; Totoki, Yasushi Y; Noë, Michaël M; Nakatani, Yoichiro Y; Horie, Masafumi M; Kawasaki, Kenta K; Nakamura, Hiromi H; Saito-Adachi, Mihoko M; Suzuki, Masami M; Takai, Erina E; Hama, Natsuko N; Higuchi, Ryota R; Hirono, Seiko S; Shiba, Satoshi S; Kato, Mamoru M; Furukawa, Eisaku E; Arai, Yasuhito Y; Rokutan, Hirofumi H; Hashimoto, Taiki T; Mitsunaga, Shuichi S; Kanda, Mitsuro M; Tanaka, Hidenori H; Takata, So S; Shimomura, Ayaka A; Oshima, Minoru M; Hackeng, Wenzel M WM; Okumura, Tomoyuki T; Okano, Keiichi K; Yamamoto, Masakazu M; Yamaue, Hiroki H; Morizane, Chigusa C; Arihiro, Koji K; Furukawa, Toru T; Sato, Toshiro T; Kiyono, Tohru T; Brosens, Lodewijk A A LAA; Wood, Laura D LD; Hruban, Ralph H RH; Shibata, Tatsuhiro T
Publication Date: 2022-03-01

Variant appearance in text: KRAS: S17E
PubMed Link: 34880079
Variant Present in the following documents:
  • 692.pdf
View BVdb publication page



High Grade of Amplification of Six Regions on Chromosome 2p in a Neuroblastoma Patient with Very Poor Outcome: The Putative New Oncogene TSSC1.

Cancers
Ognibene, Marzia M; Amoroso, Loredana L; Melchionda, Fraia F; Cangelosi, Davide D; Zara, Federico F; Parodi, Stefano S; Pezzolo, Annalisa A
Publication Date: 2021-11-18

Variant appearance in text: KRAS: S17E
PubMed Link: 34830942
Variant Present in the following documents:
  • Main text
  • cancers-13-05792.pdf
View BVdb publication page



Multi-modal meta-analysis of cancer cell line omics profiles identifies ECHDC1 as a novel breast tumor suppressor.

Molecular Systems Biology
Jaiswal, Alok A; Gautam, Prson P; Pietilä, Elina A EA; Timonen, Sanna S; Nordström, Nora N; Akimov, Yevhen Y; Sipari, Nina N; Tanoli, Ziaurrehman Z; Fleischer, Thomas T; Lehti, Kaisa K; Wennerberg, Krister K; Aittokallio, Tero T
Publication Date: 2021-03

Variant appearance in text: KRAS: S17E
PubMed Link: 33750001
Variant Present in the following documents:
  • Main text
  • MSB-17-e9526.pdf
View BVdb publication page